Travere Therapeutics, Inc. TVTX Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Travere Therapeutics, Inc.’s reported figures.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s gross profit?
- Travere Therapeutics, Inc. (TVTX) reported gross profit of $125.25M in Q1 2026.
- How has Travere Therapeutics, Inc.'s gross profit changed year-over-year?
- Travere Therapeutics, Inc.'s gross profit increased by 62.5% year-over-year, from $77.05M to $125.25M.
- What is the long-term trend for Travere Therapeutics, Inc.'s gross profit?
- Over 3 years (2022 to 2025), Travere Therapeutics, Inc.'s gross profit has grown at a 66.9% compound annual growth rate (CAGR), from $103.29M to $480.39M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.